Acquisition of VanDeMark Chemical Inc.

Uni-World Capital

Our attorneys recently represented Uni-World Capital as co-equity sponsor in the acquisition, together with co-equity sponsor Brightwood Capital, of VanDeMark Chemical Inc., a manufacturer of phosgene derivatives and North America's leading producer of merchant phosgene. Phosgene is a major industrial chemical used in the pharmaceutical, agricultural-chemical, polymer and fine chemical industries.

The transaction was sourced through Sidereal Capital, which also invested in the equity and will be appointing a director to the company. Brightwood provided mezzanine financing. VanDeMark’s senior management will continue to be significant equity owners in the company and remain in their current positions at the company.


Email Disclaimer